The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K. Baumgartner, Joshua H. Decker, Kira E. Olander et al.|Nature|2023Cited by 170
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockadeDouglas B. Fox, Daniel A. Haber, Richard Y. Ebright et al.|npj Precision Oncology|2023Cited by 17